An aging receivables report is not just a billing report. For an independent diagnostic or toxicology laboratory, it is an early warning that reimbursement processes, payer rules, documentation, or follow-up discipline are working against cash flow. Knowing how to fix aging receivables starts with treating the oldest balances as a business problem to diagnose, not simply a queue to work harder.
Receivables rarely age because of one missed call. They age when preventable issues enter the revenue cycle, claims are not segmented by their real cause, and high-value payer problems are allowed to repeat. The goal is not merely to reduce days in A/R for a month. It is to build a revenue cycle that keeps earned revenue moving from test order to payment with fewer avoidable delays.
Start With an Honest View of the A/R Inventory
The total A/R balance can hide the issues that demand immediate leadership attention. A laboratory may appear to have a manageable overall days-in-A/R figure while carrying a growing concentration of balances beyond 90, 120, or 180 days. At that point, collectability declines, staff time rises, and timely filing limits may be approaching or already lost.
Segment aging receivables before assigning follow-up work. Review balances by payer, plan, claim age, location or ordering client, test category, denial reason, dollar value, and payer responsibility versus patient responsibility. For toxicology and other diagnostic laboratories, also separate claims affected by medical necessity edits, prior authorization issues, frequency limitations, modifier concerns, missing documentation, and eligibility failures.
This review should answer practical questions. Which payers are producing the largest dollar exposure? Which denial categories are recurring? Are claims aging because they were never adjudicated, because they were denied, or because the payer requested information that was not returned? Do certain ordering providers, collection sites, or test panels create more documentation exceptions?
Aging reports become useful when they reveal patterns. A $20,000 bucket spread across hundreds of low-balance patient accounts requires a different strategy than $20,000 tied to a single payer edit affecting a specific toxicology code combination.
Prioritize Aged Claims by Recovery Opportunity
Working accounts in date order alone can consume resources without producing meaningful cash. The better approach is to rank work by recoverability, value, payer behavior, and filing risk.
Claims nearing a payer’s timely filing deadline should receive immediate attention, especially when proof of timely submission is available. Next, focus on higher-dollar claims with clear correction paths, such as a missing modifier, a coding correction supported by documentation, or a claim that requires a formal reconsideration. Claims with repeated payer processing errors may warrant escalation through provider relations or a structured payer dispute process rather than another routine status call.
Not every old account deserves the same level of effort. A disciplined team defines when to appeal, when to rebill, when to pursue patient responsibility, and when further activity is unlikely to justify the cost. That decision should be based on documented recovery criteria, not individual collector preference.
Build Work Queues That Match the Problem
A single generic follow-up queue makes it harder to measure performance and easier for complex denials to sit untouched. Create distinct work queues for unadjudicated claims, correctable denials, appeals, documentation requests, credit-balance-related holds, and patient balances.
Each queue needs an owner, a next action date, and a clear escalation path. For example, a claim awaiting medical records should not remain in the same queue as a payer denial requiring coding review. Clear ownership keeps accounts from cycling through notes without a meaningful resolution.
Find the Root Cause Before Chasing More Claims
The fastest way to reduce old A/R is often to stop adding to it. If the same denial is appearing every week, more follow-up staff will only increase the cost of managing a preventable problem.
Begin with the denial reasons that create the greatest financial exposure. In laboratory billing, common root causes include inaccurate patient demographics, coverage inactive on the date of service, missing or invalid ordering provider information, uncredentialed providers, diagnosis-code mismatches, insufficient documentation of medical necessity, and payer-specific billing edits. Complex test panels can also create issues when coding, modifiers, units, or frequency rules are not aligned with the payer’s policy.
Review the full path of a sample claim. Look at the order, requisition, patient registration information, insurance verification, charge capture, coding, claim submission, payer response, and follow-up notes. This often identifies a break in the process that is not visible from the denial code alone.
For example, a payer may deny a toxicology claim for medical necessity, but the operational cause may be incomplete diagnosis information on the requisition or an ordering source that is not consistently supplying supporting documentation. The corrective action is not simply to appeal each claim. It may involve updating intake requirements, educating ordering clients, improving documentation retrieval, and monitoring future claims from that source.
Strengthen Front-End Controls
A/R cleanup produces the best results when it is paired with stronger prevention. Laboratories should confirm eligibility and benefits as early as possible, capture complete demographic and insurance information, and validate ordering provider details before billing. Credentialing and enrollment issues require particular attention because claims can age quickly when a payer cannot recognize the billing relationship correctly.
Front-end controls should be practical and payer-specific. A broad checklist is helpful, but staff also need clear guidance for plans with unique authorization, ordering, documentation, or frequency requirements. Maintain current payer rules in a process that the billing and operations teams can actually use.
Quality checks should focus on the errors most likely to delay payment. If a laboratory sees a rise in claims rejected for subscriber information, measure registration accuracy. If denials center on diagnosis support, audit requisitions and coding before claims go out. The most valuable control is the one that addresses a measured source of rework.
Make Denial Management a Revenue Strategy
Denials are data. When they are categorized accurately and reviewed regularly, they show where revenue is leaking and where operational changes can produce the strongest return.
Track denial volume and dollars by payer, reason, test category, and root cause. Separate denials that are preventable from those that require a payer appeal or contract review. Then assign an accountable leader to each recurring issue and set a deadline for corrective action.
A productive denial-management process includes four disciplines:
- Accurate denial coding and root-cause classification
- Timely, well-supported appeals for claims that should be paid
- Payer escalation for recurring processing or policy issues
- Preventive workflow changes that reduce future denials
Appeals should be selective and complete. A vague appeal letter with incomplete records adds another delay and can weaken the laboratory’s position. Submit the documentation, clinical support, claim history, and policy-based rationale needed for the payer to reconsider the claim. Track appeal outcomes so the team can identify which arguments, payers, and claim types justify continued effort.
Hold Payers Accountable With Better Documentation
Payer follow-up should be structured, not repetitive. For each significant aged account, maintain accurate notes that show the claim status, reference number, payer representative, requested action, appeal level, and next follow-up date. This documentation matters when a claim must be escalated, reconsidered, or defended against a timely filing denial.
Measure payer performance as well. If one plan consistently delays adjudication, misprocesses claims, or applies edits inconsistently, quantify the financial impact. A pattern supported by claim-level evidence gives laboratory leaders a stronger basis for payer discussions, contracting decisions, and operational planning.
It also helps to distinguish payer delays from internal delays. A claim that has not been touched for 45 days because the team lacks a work queue is an internal process issue. A clean claim held beyond the payer’s standard processing period is a payer-management issue. Both deserve attention, but they require different solutions.
Manage Patient Balances With Clarity and Consistency
Patient responsibility can become a significant aging category, particularly when coverage information is incomplete or high-deductible plans create unexpected balances. The approach should balance collection performance with the patient experience.
Send statements promptly, use clear descriptions, and make it straightforward for patients to ask questions or arrange payment. Validate insurance before moving a balance to patient responsibility whenever possible. A patient should not be asked to resolve a balance that is actually caused by a missing payer follow-up action or an unresolved eligibility issue.
For balances that are legitimately patient responsibility, establish consistent policies for statement cycles, payment plans, financial assistance where applicable, and escalation. Consistency protects the patient relationship while preventing small balances from becoming an unmanaged aging category.
Monitor the Measures That Drive Improvement
Reducing aging A/R requires more than a month-end report. Leaders should review total days in A/R, the percentage of A/R over 90 days, net collection rate, denial rate, clean-claim rate, appeal overturn rate, and cash collected from aged inventory. Review these measures by payer and by service line when the data supports it.
The trend matters as much as the current number. If old A/R falls while denial volume rises, the team may be resolving legacy balances without correcting the source of new ones. If cash improves only because staff wrote off difficult claims, the apparent progress may not be sustainable.
For independent laboratories, the right answer may be a focused internal cleanup project, revised payer workflows, additional billing expertise, or a broader revenue cycle assessment. It depends on whether the challenge is capacity, process design, payer knowledge, credentialing, or a combination of factors. The strongest results come from connecting aged receivables work to the full lifecycle of reimbursement, then acting on what the data shows.
A healthy A/R portfolio gives laboratory leaders more than improved cash flow. It creates the financial control needed to invest confidently in operations, client relationships, and long-term growth.
Recent Comments